In This Article:
Amidst a backdrop of global market volatility driven by tariff uncertainties and mixed economic indicators, investors are increasingly seeking stable income sources to navigate these turbulent times. Dividend stocks often provide a reliable stream of income and can be an attractive option for those looking to balance their portfolios with consistent returns, especially when market conditions are unpredictable.
Top 10 Dividend Stocks
| Name | Dividend Yield | Dividend Rating |
| Tsubakimoto Chain (TSE:6371) | 4.21% | ★★★★★★ |
| Wuliangye YibinLtd (SZSE:000858) | 4.04% | ★★★★★★ |
| Peoples Bancorp (NasdaqGS:PEBO) | 4.89% | ★★★★★★ |
| Daito Trust ConstructionLtd (TSE:1878) | 4.03% | ★★★★★★ |
| Southside Bancshares (NYSE:SBSI) | 4.58% | ★★★★★★ |
| China South Publishing & Media Group (SHSE:601098) | 4.13% | ★★★★★★ |
| Citizens & Northern (NasdaqCM:CZNC) | 5.16% | ★★★★★★ |
| DoshishaLtd (TSE:7483) | 3.87% | ★★★★★★ |
| FALCO HOLDINGS (TSE:4671) | 6.47% | ★★★★★★ |
| Yamato Kogyo (TSE:5444) | 3.85% | ★★★★★★ |
Click here to see the full list of 1961 stocks from our Top Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Banca Popolare di Sondrio
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Banca Popolare di Sondrio S.p.A., along with its subsidiaries, offers a range of banking products and services in Italy and has a market capitalization of approximately €4.21 billion.
Operations: Banca Popolare di Sondrio S.p.A. operates through various revenue segments, providing a diverse array of banking products and services across Italy.
Dividend Yield: 8.5%
Banca Popolare di Sondrio's dividend yield is among the top 25% in the Italian market, with a payout ratio of 62.6%, indicating dividends are well-covered by earnings. However, its dividend track record has been volatile and unreliable over the past decade. Recent earnings growth and a proposed acquisition by BPER Banca SpA valued at €4.32 billion could influence future dividend stability and growth potential, subject to regulatory approvals and integration success.
China Medical System Holdings
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: China Medical System Holdings Limited is an investment holding company that manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China, with a market cap of HK$18.24 billion.
Operations: The company's revenue primarily comes from the marketing, promotion, sales, and manufacturing of pharmaceutical products, amounting to CN¥7.01 billion.